Look at what’s new in D.C.

Program for 2011 BIO International Convention seeks to provide attendees with a well-rounded knowledge base they can use to advance business objectives
| 13 min read
Written byJeffrey Bouley
Program for 2011 BIO International Convention seeks to provide attendees with a well-rounded knowledge base they can use to advance business objectives

WASHINGTON, D.C.—With themes for its 2011 BIO International Convention focused around the concepts of "Leadership, Partnerships and Breakthroughs," the Biotechnology Industry Organization (BIO) brings insights into the business of biotech to Washington, D.C., this year—the city where BIO itself is headquartered—after a jaunt to Chicago last year for the event.

BIO bills the event as a place where decision-makers in various biotechnology industries come to form partnerships, evaluate the latest technologies and discover new players, adding that "the BIO Exhibition is where they get a snapshot of the evolving industry each year."

The exhibition, like the rest of the June 27-30 convention, is being held at the Walter E. Washington Convention Center, and the exhibits will be broken down into five themed, or "product focus," areas. There is the BioProcess Zone, where you can see companies and organizations focused on upstream and downstream processing, manufacturing, custom outsourcing, information technology and regulatory compliance; the Clinical Trials Zone, focused on clinical trial management, injectable delivery technologies, oral drug delivery technologies, biomarkers and the U.S. Food and Drug Administration's (FDA) Critical Path; the Contract Services Zone, with its biopharmaceutical and pharmaceutical contract research and manufacturing entities ranging from preclinical to clinical to commercial; the Discovery Zone, a place to find new and unique techniques for developing innovations in imaging, lab automation and supplies, software and hardware; and the Business Services Zone, where such players as law firms, logistics providers, consulting firms, office equipment/services and business support organizations can be found.

The exhibit floor pretty much covers the "breakthrough" part of its three-part theme, but what about "leadership" and "partnerships?"

For the former, BIO is highlighting its "Can't-Miss Monday" programming, which it says will feature "some of the biggest names in biotech." Those Monday programs begin with "Biotech Primer: Bio-Baffled?" at 10 a.m., and continues with "Leadership Summit: Deploying Agricultural and Industrial Biotechnologies to Meet Development Challenges" from 1 p.m. to 4:15 p.m. and "Translational Research Forum and Reception: Translational Medicine—A Global Endeavor" from 1 p.m. to 6 p.m.

That isn't the only leadership-themed set of offerings, of course, and another one of note is the new "Emerging Leaders Workshop: Invest in Your Company's Future." The workshop is designed for mid-level product planners and marketing managers who have two to five years of experience and would like to master the skills of strategic planning, collaboration and logistics to successfully bring new products to the market. It will take place Monday, June 27 from 8:45 a.m. to 5 p.m. and Tuesday, June 28, from 8:45 a.m. to 12:30 p.m.

Finally, the "partnering" part can be found in its most obvious form at the BIO Business Forum, which takes place more or less from 8 a.m. to 4:30 Tuesday, Wednesday and Thursday—although the Tuesday part of the "partnering" begins at 10 a.m. and is both preceded and overlapped by Business Forum company presentations from 9 a.m. to 11 a.m.

BIO encourages attendees to come to the partnering events with a team and be ready to discuss strategic goals.

"Thousands of companies from around the world and across all industry segments will be in the BIO Business Forum with a shared goal—to build relationships that lead to successful partnerships and breakthrough solutions," touts Jim Greenwood, BIO's president and CEO. Through its BIO One-on-One Partnering system, BIO expects to facilitate more than 17,000 face-to-face meetings involving more than 2,100 companies, all in three days.


To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Published In

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

A network of interconnected human icons overlaid on a world map, representing global collaboration and population-scale data connections.
New collaborative initiatives are bringing pharmaceutical R&D together around large-scale datasets to accelerate therapeutic discovery.
Modeling neurotropic viral infections using human cerebral organoids
Using fetal-stage brain organoids, researchers are uncovering how Zika virus impacts neurodevelopment and contributes to microcephaly. 
Completing the real-time data picture in bioprocess development
Explore approaches to integrating timely protein titer measurements with cell health data to improve bioprocess visibility and decision-making.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue